SCD-1 is highly expressed in the hearts of patients with obesity or diabetes, and an increase in SCD-1 alleviates SFA-induced adverse FA catabolism and eventually prevents SFA-induced apoptosis [34]. Here, SCD is linked to obesity disorder.